{"name":"Anebulo Pharmaceuticals","slug":"anebulo-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":4299941,"netIncome":-8484763,"cash":11627849,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-02-12","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2026-02-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPSzhPbGVBdEFLNW1zcDdhaUFabDYwbXBIVUxOUWx5MkRWTUZrUWE4RkxOTndVSDNXQkFnRlZsZkJwX3p3N0lBaHFQMzd1c0RzZjdxZ0N5YWlVMS1UeTVWcTIyR2Z4YkFGbUJCZlpDYTFXbWNXRmRicFl0YVJvTkpYS1V0NjJvQm43QWJTV0JFcFN0Vk9RME1xLVlVZDJpaVAyUlVZUm03cGh5VWREWEtTV3RLOWdpN1U0ZEN2TA?oc=5","date":"2026-02-06","type":"pipeline","source":"Stock Titan","summary":"Anebulo Pharma plans Nasdaq exit to cut SEC reporting costs - Stock Titan","headline":"Anebulo Pharma plans Nasdaq exit to cut SEC reporting costs","sentiment":"neutral"},{"date":"2026-02-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-29","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxOUVl3NkpTMURmUjFBMW1QbmlDVnZYdUFucWZwTEo4THVWdHEtOFNYcGF0YWEzWGZQSTdFRDRyQkhvaHlkWHVkajIzOGh3bjRyX0RHNlNRU2ZrcTd3STE5bWpTWUNMYmN0ZEdraGJoZG1NOE5uYjVUZkI2UW1LOV91QmRVcHk0SUwxS2dBTURRbkVoUmNOcmJ0b2hjb09LSEowd2N6TkQwc0pHZGFLNW53VklRZ2tJZHJudjFoRmhuRzRjWkdPa1lTUE1lNHBVN0J4Qk1ybVk0Y3V0X2NhdTBOVXNtVm55RXdyU3NHTHhR0gHzAUFVX3lxTE9OYy1OaHV4dUI2OFUtaGRYaWU0Zl9xYzItUVMtTHJ2M255Nk13Sld5OUNnQm91VEt5VFByZ0FvR013cms5Rks0NU0tNHNndXEzQ0V0U2RPZ082MUhjazVDSmc5MFZLelVXN1kyWVBJUGR6WGNvWmpRVnBQQTVUbFNKSEVmNFdaOXE4SEZVYmFZeTZIdDN4TlIyX1lRMDl1UDB5VTFFMU1veTcxRXl0NkdsNGQwZkNiYTJLX1lfeUxMemt5XzRXR1ViSlNhQXhtZUgzZ1J6MzZEMWxZeU9Ib0QxLXdjRUdXOHJnUlQzRklZdHJfaw?oc=5","date":"2025-12-23","type":"pipeline","source":"simplywall.st","summary":"We're Hopeful That Anebulo Pharmaceuticals (NASDAQ:ANEB) Will Use Its Cash Wisely - simplywall.st","headline":"We're Hopeful That Anebulo Pharmaceuticals (NASDAQ:ANEB) Will Use Its Cash Wisely","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPZDVqajBicHdqMXdTWG56b1hpcmFGZEFjcVZNblptRWNJNGVCQXczZjZCcmM5TzgyNUlLNzZmSGpyUkJ5UkhQeDRHc0wybVpBb2U4VnIxYkRhWUl2NUdlbVJDXzVvcGpLSnFxNUxVRFhneGowRlFfeTF1UDA5QTlwOVdNMTdmMDFLNDZsaDdkTVIxVzRoWUVjU2NoRFVfU0hZSXZDZ2V0cVZqeEw5THF2emhlY2ZfbXBQaWc?oc=5","date":"2025-12-22","type":"deal","source":"Stock Titan","summary":"Drug developer drops reverse split, plans cash buyback to go private - Stock Titan","headline":"Drug developer drops reverse split, plans cash buyback to go private","sentiment":"neutral"},{"date":"2025-12-22","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-13","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-11-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-09-29","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2025-09-29","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPUWI4WlgyZTJ5MjdRQVBQT0FGUWU3MFFBWkpxOEdjX2s1MzZ5RktHaGhEOHEtTTlwNVFBQTZqdFhYZElYVW1XTjJreUFuTmVoMHladGZQSXFhd09xNVM1andXaGdFMHdRTE1FMy1pVEJUWUhINDc1V2Y4bVRXZFBjMVZoc05GRkxOSS1CU01qYXdsMjZNR2xHOGV0OWcyOVotanpMRWRteFQzYVJvdlVnMk9fS25LTUhrZHJqcVpMeF9Zd002eEwySTNWVHA5UU94SVpUTWF6OA?oc=5","date":"2025-07-23","type":"regulatory","source":"Business Wire","summary":"Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock - Business Wire","headline":"Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE5aS0tNbUx6ZjBhN2Y4ZHJYNmxYYmZHOUl6eFliYkQ2UWJzcDZ4WWhWeV9DSlZJdC03bWUwbFlnRE5DX3BhaDV3UmdoRFpvWjIyZ1UzQm41ajhvazRHOTZVdXprQXZEZXNqbGgxM0diWW1sNUFv?oc=5","date":"2023-10-06","type":"pipeline","source":"BioSpace","summary":"Anebulo Pharmaceuticals Announces New CEO - BioSpace","headline":"Anebulo Pharmaceuticals Announces New CEO","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":4299941,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-8484763,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":11627849,"cashHistory":[],"totalAssets":12145616,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}